Éligibilité des patients aux cellules CAR-T : avis d’experts proposé par la SFGM-TC-Reference-Cited by-同舟云学术

Éligibilité des patients aux cellules CAR-T : avis d’experts proposé par la SFGM-TC

Published:2021-07 Issue:7-8 Volume:108 Page:725-729
ISSN:0007-4551
Container-title:Bulletin du Cancer
language:fr
Short-container-title:Bulletin du Cancer

Author:

Beauvais David,Bachy Emmanuel,Baruchel André,Bay Jacques-Olivier,Caillot Denis,Cartron Guillaume,Damaj Gandhi,Furst Sabine,Le Gouill Steven,Morschhauser Franck,Rabian Florence,Rubio Marie-Thérèse,Thieblemont Catherine,Yakoub-Agha Ibrahim

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Reference15 articles.

1. Expression of chimeric receptor composed of immunoglobulin-derived V regions and T-cell receptor-derived C regions;Kuwana;Biochem Biophys Res Commun,1987

2. Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity;Gross;Proc Natl Acad Sci U S A.,1989

3. CAR T-cells: A John von Neumann legacy?;Quesnel;Curr Res Transl Med.,2018

4. The basic principles of chimeric antigen receptor design;Sadelain;Cancer Discov,2013

5. Chimeric antigen-receptor T-cell therapy for hematological malignancies and solid tumors: clinical data to date, current limitations and perspectives;Gauthier;Curr Res Transl Med,2017

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Practice harmonization workshops of EBMT: an expert-based approach to generate practical and contemporary guidelines within the arena of hematopoietic cell transplantation and cellular therapy;Bone Marrow Transplantation;2023-03-27

2. Clinical and Product Features Associated with Outcome of DLBCL Patients to CD19-Targeted CAR T-Cell Therapy;Cancers;2021-08-25

3. Effects of the COVID-19 pandemic on publication landscape in chimeric antigen receptor-modified immune cell research;2021-06-02